When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?

摘要

Objective: To evaluate the efficacy and safety of adding sulfasalazine to leflunomide treatment compared with switching to sulfasalazine alone in patients with RA with an inadequate response to leflunomide monotherapy.